Market Cap

Xiangxue Pharmaceutical Co.,Ltd. Market Capitalization:

CN¥5.53 Billion

CNY as of July 1, 2025

US$772.6 Million

business Xiangxue Pharmaceutical Co.,Ltd. Company Profile

Xiangxue Pharmaceutical Co.,Ltd. Main Stock Listing

SZSE: 300147

Market Capitalization History of Xiangxue Pharmaceutical Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Xiangxue Pharmaceutical Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2025 CN¥8.85 B 161.52%
Jan. 1, 2024 CN¥3.39 B -11.42%
Jan. 1, 2023 CN¥3.82 B -14.73%
Jan. 1, 2022 CN¥4.48 B -14.91%
Jan. 1, 2021 CN¥5.27 B -29.38%
Jan. 1, 2020 CN¥7.46 B 83.14%
Jan. 1, 2019 CN¥4.07 B -31.29%
Jan. 1, 2018 CN¥5.93 B -25.42%
Jan. 1, 2017 CN¥7.95 B -19.68%
Jan. 1, 2016 CN¥9.90 B -10.79%
Jan. 1, 2015 CN¥11.09 B -5.17%
Jan. 1, 2014 CN¥11.70 B 163.22%
Jan. 1, 2013 CN¥4.44 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Xiangxue Pharmaceutical Co.,Ltd. Categories

China languages Healthcare languages Biotechnology
China Healthcare China Biotechnology

Stocks & Indices

Xiangxue Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: SZSE: 300147

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.